Skip to main content
. Author manuscript; available in PMC: 2021 Jan 17.
Published in final edited form as: ChemMedChem. 2019 Dec 4;15(2):210–218. doi: 10.1002/cmdc.201900560

Table 1.

Colistin MICs against AB 4106 and KP B9 in the presence of lead IMD-0354 analogues

Compounda AB 4106 MIC (μg/mL) (fold reduction) KP B9 MIC (μg/mL) (fold reduction)
IMD-0354 2 (1024)b 0.5 (1024)c
9 2 (1024) 0.25 (2048)
10 0.5 (4096) 0.5 (1024)
15 1 (2048) 0.25 (2048)
22 2 (1024) 0.25 (2048)
23 2 (1024) 0.25 (2048)
24 0.5 (4096) 0.5 (1024)
25 1 (2048) 0.25 (2048)
26 1 (2048) 0.25 (2048)
29 1 (2048) 0.5 (1024)
37 1 (2048) 0.25 (2048)
43 2 (1024) 0.125 (4096)
49 1 (2048) 0.25 (2048)
50 4 (512) 0.25 (2048)
51 1 (2048) 0.125 (4096)
52 1 (2048) 0.5 (1024)
55 1 (2048) 0.5 (1024)
56 1 (2048) 0.5 (1024)
60 1 (2048) 0.5 (1024)
a

All compounds screened at 5 μM.

b

MIC of colistin alone is 2048 μg/mL.

c

MIC of colistin alone is 512 μg/mL.